Related references
Note: Only part of the references are listed.The STARS Phase 2 Study A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome
Lynne M. Bird et al.
NEUROLOGY (2021)
Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study
James Robert Brasic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Feasibility of a Complex Setting for Assessing Sleep and Circadian Rhythmicity in a Fragile X Cohort
Alexander Dueck et al.
FRONTIERS IN PSYCHIATRY (2020)
Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome
Debra L. Reisinger et al.
BRAIN SCIENCES (2020)
PIVOTAL STUDY OF ZYN002 CANNABIDIOL (CBD) TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH FRAGILE X SYNDROME: ROLE OF METHYLATION STATUS AS A CORRELATE TO DISEASE SEVERITY AND PROGNOSTIC BIOMARKER
Elizabeth Berry-Kravis et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2020)
Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
Skylar Luu et al.
BRAIN SCIENCES (2020)
A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments
Dejan B. Budimirovic et al.
BRAIN SCIENCES (2020)
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
James R. Brasic et al.
BRAIN SCIENCES (2020)
Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance
Lauren E. Ethridge et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2019)
Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions
Kyoungmi Kim et al.
PLOS ONE (2019)
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis
Eleanor M. Eckert et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2019)
Molecular Biomarkers in Fragile X Syndrome
Marwa Zafarullah et al.
BRAIN SCIENCES (2019)
Exploring the Sensory Profiles of Children on the Autism Spectrum Using the Short Sensory Profile-2 (SSP-2)
Kate Simpson et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2019)
Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities
Jayne Dixon Weber et al.
BRAIN SCIENCES (2019)
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Elizabeth M. Berry-Kravis et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results
Eriene A. Youssef et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Sensory Difficulties in Children With an FMR1 Premutation
Melissa Raspa et al.
FRONTIERS IN GENETICS (2018)
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
Anna W. Lee et al.
BRAIN SCIENCES (2018)
Autism Symptoms in Fragile X Syndrome
Manman Niu et al.
JOURNAL OF CHILD NEUROLOGY (2017)
Arbaclofen in fragile X syndrome: results of phase 3 trials
Elizabeth Berry-Kravis et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2017)
Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
Dejan B. Budimirovic et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2017)
Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment
Walter E. Kaufmann et al.
PEDIATRICS (2017)
FRAGILE X SYNDROME: LESSONS LEARNED FROM THE MOST TRANSLATED NEURODEVELOPMENTAL DISORDER IN CLINICAL TRIALS
Phan Q. Duy et al.
TRANSLATIONAL NEUROSCIENCE (2017)
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
Elizabeth Berry-Kravis et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Altered expression of delta GABA(A) receptors in health and disease
Paul D. Whissell et al.
NEUROPHARMACOLOGY (2015)
Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala
Brandon S. Martin et al.
JOURNAL OF NEUROPHYSIOLOGY (2014)
The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type
Vallent Lee et al.
FRONTIERS IN NEURAL CIRCUITS (2014)
Improving IQ measurement in intellectual disabilities using true deviation from population norms
Stephanie M. Sansone et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2014)
Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics
Claudia Bagni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease
Stephen G. Brickley et al.
NEURON (2012)
FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States
Flora Tassone et al.
GENOME MEDICINE (2012)
Psychometric Study of the Aberrant Behavior Checklist in Fragile X Syndrome and Implications for Targeted Treatment
Stephanie M. Sansone et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2012)
Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome
Elizabeth Berry-Kravis et al.
INTERNATIONAL JOURNAL OF PEDIATRICS (2012)
Effect of a vitamin/mineral supplement on children and adults with autism
James B. Adams et al.
BMC PEDIATRICS (2011)
The GABA(A) Receptor Agonist THIP Ameliorates Specific Behavioral Deficits in the Mouse Model of Fragile X Syndrome
Jose Luis Olmos-Serrano et al.
DEVELOPMENTAL NEUROSCIENCE (2011)
Psychiatric and Autistic Comorbidity in Fragile X Syndrome Across Ages
Lidia V. Gabis et al.
JOURNAL OF CHILD NEUROLOGY (2011)
Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization
Lisa Cordeiro et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2011)
Defective GABAergic Neurotransmission and Pharmacological Rescue of Neuronal Hyperexcitability in the Amygdala in a Mouse Model of Fragile X Syndrome
Jose Luis Olmos-Serrano et al.
JOURNAL OF NEUROSCIENCE (2010)
Advances in the Treatment of Fragile X Syndrome
Randi J. Hagerman et al.
PEDIATRICS (2009)
The repetitive behavior scale-revised: Independent validation in individuals with autism spectrum disorders
Kristen S. L. Lam et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2007)
Expression profiling suggests underexpression of the GABAA receptor subunit δ in the fragile X knockout mouse model
I Gantois et al.
NEUROBIOLOGY OF DISEASE (2006)
Autism spectrum disorder in fragile X syndrome: Differential contribution of adaptive socialization and social withdrawal
Dejan B. Budimirovic et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
GABAA receptor-mediated tonic inhibition in thalamic neurons
DW Cope et al.
JOURNAL OF NEUROSCIENCE (2005)
FMR1 and the fragile X syndrome:: Human genome epidemiology review
DC Crawford et al.
GENETICS IN MEDICINE (2001)
Share Paper
